Lesl R

Biography

Lesley Russell, M.D. has been a director since December 2009. Dr. Russell served as chief medical officer of Innocoll Holdings from April 2016 until November 2017. She previously served as the chief operating officer of TetraLogics Pharmaceuticals from August 2013 until April 2016. Prior to TetraLogics, she was the senior vice president and global head of research and development for Teva Pharmaceuticals, Inc., a role which she was appointed to after Teva acquired Cephalon. While at Cephalon from 2006 to 2011, Dr. Russell served as executive vice president and chief medical officer. Prior to joining Cephalon in 2000, Dr. Russell worked for several pharmaceutical organizations, including US Biosciences, Eli Lilly and Company and Amgen. Before joining the pharmaceutical industry, she was trained in hematology/oncology at Royal Infirmary of Edinburgh and at Royal Hospital for Sick Children in Edinburgh, UK, and was a Research Fellow at University of Edinburgh Faculty of Medicine. Dr. Russell currently serves on the board of directors of Endoycte, Inc. and Enanta Pharmaceuticals. Dr. Russell received Bachelor of Medicine and Bachelor of Surgery degrees from the University of Edinburgh. She is a member of the Royal College of Physicians and is registered with the General Medical Council.

Research Interest

chemistry